Andrew Koven joins Inspire
This article was originally published in Scrip
Executive Summary
Andrew Koven has been appointed to the newly created position of executive vice-president and chief administrative and legal officer at Inspire Pharmaceuticals (US), effective 10 May. He has been executive vice-president, general counsel and corporate secretary at Sepracor since 2007. Inspire is researching, developing and commercialising prescription drugs for ophthalmic and pulmonary diseases.